Readers of this blog are, by now, aware of the many issues surrounding Merck’s blockbuster nonsteroidal, anti-inflammatory medication Vioxx (rofecoxib) and negative cardiac events. The cardiac problems associated with Vioxx, and its subsequent withdrawal from the market, spawned scores of lawsuits. These include Merck shareholder lawsuits, which were recently the subject of oral [ ]
Lawyer reprimanded in Vioxx case
ATLANTIC CITY, N.J. (AP) The judge hearing a product liability suit against Merck & Co., the manufacturer of painkiller Vioxx, reprimanded the company s lead lawyer Thursday for violating pretrial instructions barring comments about lawyers in front of the jury.
Tumour Necrosis Factor alpha (TNF-alpha) blocking agents cause skin disease
Last year saw the withdrawal of frontline anti-arthritis drug Vioxx, which belongs to the cox-2 inhibitors family, when it was revealed that it poses a significant risk of heart attack and stroke.
Merck to Enter a Venture for Pain Drugs
Merck & Company, stung by the withdrawal of Vioxx from the market, will enter a collaboration with Neuromed Pharmaceuticals to develop new painkilling drugs.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved